These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 402747)

  • 41. Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.
    Oravisto KJ
    Scand J Urol Nephrol; 1972; 6(1):26-8. PubMed ID: 4626940
    [No Abstract]   [Full Text] [Related]  

  • 42. [Regional intra-arterial chemotherapy in tumors of the urinary bladder].
    Taukenov MT; Minakova LR
    Urol Nefrol (Mosk); 1967; 32(5):76-80. PubMed ID: 4983861
    [No Abstract]   [Full Text] [Related]  

  • 43. [Local treatment of carcinomatous effusions with triethylenethiophosphoramide (thio-tepa)].
    Schwandt P; Ehrhart H
    Munch Med Wochenschr; 1966 Dec; 108(50):2535-40. PubMed ID: 4166193
    [No Abstract]   [Full Text] [Related]  

  • 44. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 45. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.
    O'Dwyer PJ; LaCreta F; Nash S; Tinsley PW; Schilder R; Clapper ML; Tew KD; Panting L; Litwin S; Comis RL
    Cancer Res; 1991 Nov; 51(22):6059-65. PubMed ID: 1933869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recurrence prevention of papillomas of the bladder using lycurim instillation].
    Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J
    Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of thio-tepa on the microbial flora of the urine in bladder neoplasms].
    Stetsenko DV
    Urol Nefrol (Mosk); 1972; 37(6):55-6. PubMed ID: 4198610
    [No Abstract]   [Full Text] [Related]  

  • 51. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI; Savvin VT
    Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
    Madrigal Alonso PL; Perez Gomez FJ
    Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
    [No Abstract]   [Full Text] [Related]  

  • 54. Topical use of Thio-Tepa for tumours of the bladder.
    Oravisto KJ
    Urol Int; 1965; 20(1):23-8. PubMed ID: 4953655
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.
    Hagen B; Neverdal G; Walstad RA; Nilsen OG
    Cancer Chemother Pharmacol; 1990; 25(4):257-62. PubMed ID: 1688514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Acta Med Philipp; 1965; 1():124-6. PubMed ID: 14283247
    [No Abstract]   [Full Text] [Related]  

  • 57. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Philipp J Surg Surg Spec; 1964; 19():332-7. PubMed ID: 14260308
    [No Abstract]   [Full Text] [Related]  

  • 58. Early multiple-dose adjuvant thiotepa in the control of multiple and rapid T1 tumour neogenesis.
    England HR; Flynn JT; Paris AM; Blandy JP
    Br J Urol; 1981 Dec; 53(6):588-92. PubMed ID: 6797501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The effect of the drug thio-TEPA on the microbial flora of the urine of patients with urinary bladder neoplasms].
    Stetsenko DV
    Klin Khir (1962); 1972 Oct; 10():82. PubMed ID: 4633206
    [No Abstract]   [Full Text] [Related]  

  • 60. THE TOPICAL USE OF CYTOTOXIC DRUGS FOR BLADDER CANCER.
    JONES HC
    Proc R Soc Med; 1963 Aug; 56(8):751-2. PubMed ID: 14052473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.